---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-103722"
form_type: "8-K"
ticker: "GKOS"
cik: "0001192448"
company_name: "GLAUKOS Corp"
filed_at: "2025-10-29T23:59:59+00:00"
generated_at: "2026-05-17T01:35:05.967323+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Glaukos Q3 revenue $133.5M (+38% YoY); raises 2025 guide, introduces 2026 outlook

## Summary
- Record net sales $133.5M, up 38% YoY; U.S. Glaucoma sales $80.8M (+57% YoY).
- GAAP net loss $16.2M (($0.28)/share) improved from $21.4M loss prior year; non-GAAP loss $9.2M (($0.16)/share).
- Raised FY2025 net sales guidance to $490-495M (from $480-486M); introduced preliminary FY2026 guidance $600-620M.
- Gross margin ~78% (non-GAAP ~84%); ended quarter with $277.5M cash, no debt.

## SEC filing metadata
- accession: 0001104659-25-103722
- form_type: 8-K
- ticker: GKOS
- cik: 0001192448
- company_name: GLAUKOS Corp
- filed_at: 2025-10-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1192448/000110465925103722/0001104659-25-103722-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1192448/000110465925103722/gkos-20251029x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-103722
- JSON: https://secwatch.observer/filing/0001104659-25-103722.json
- Plain text: https://secwatch.observer/filing/0001104659-25-103722.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.